IDLC Securities
IDLC Securities

IDLC Securities

Coverage: Bangladesh
IDLC is a leading brokerage firm in Bangladesh and a trusted name to both international & domestic investors with its proven track record of research expertise, quality corporate access, and standards of regulatory compliance and corporate ethics.
Location: Dhaka

Latest from IDLC Securities

Olympic Industries: Q1 FY23: c13% yoy earnings growth driven by c38% revenue growth

The c38% growth in top-line revenue was the main driver of yoy earnings growth. The scale of growth in top-line revenue is attributable to the company’s ‘Shrinkflation’ strategy. Gross margin declined by 198bps yoy but improved by 543bps qoq.
IDLC Securities Shopnil
Shopnil Paul @ IDLC Securities 21 November 2022
Flash Report / Bangladesh

Bangladesh regulators allow block trades up to 10% below the floor price

Regulators will allow block trades below the floor price set on 31st July 2022. Please note that this new lower price limit for a stock is subject to its circuit breaker. When a stock reaches its floor, the circuit breaker will be calculated based on...
IDLC Securities Tanay
Tanay Kumar Roy @ IDLC Securities 15 November 2022

Square Pharmaceuticals: Q1 FY23: EPS rose c10% yoy, due to higher revenue growth, forex gain and margin.

EPS in Q1 FY23 stood at BDT 6.20 against BDT 5.64 reported in Q1 FY22. SQURPHARMA’s revenue growth was one of the highest among its peers in Q1 FY23. Exchange rate gain rose from BDT 31 mn in Q1 FY22 to BDT 399 mn in Q1 FY23.
IDLC Securities Tanay
Tanay Kumar Roy @ IDLC Securities 15 November 2022

Renata: Q1'23: EPS -9.9% yoy, due to high financial & operating costs, and margin dent

EPS fell from BDT 12.90 in Q1 FY22 to BDT 11.62 in Q1 FY23. Gross margin fell by 44 bps while Opex/Sales rose by 190 bps in Q1 FY23. Financial expenses increased to BDT 286 mn in Q1 FY23 driven by rise in outstanding loan balance and BDT depreciation...
IDLC Securities Tanay
Tanay Kumar Roy @ IDLC Securities 15 November 2022

Bangladesh Submarine Cable Co: Q1 FY23: c35% yoy earnings growth driven by c37% revenue growth

The earnings growth is driven by the c37% growth in revenue. Gross margin and opex to sales ratio improved this quarter. 37% yoy growth in top-line revenue in Q1 FY23 and the main revenue contributor, IPLC rent increased by c40% YoY. Gross margin imp...
IDLC Securities Shopnil
Shopnil Paul @ IDLC Securities 15 November 2022

IBN SINA Pharmaceutical: IBNSINA Q1 FY23: C2% yoy earnings growth driven by c4% yoy revenue growth

Challenging macroeconomic conditions, and higher revenue growth base in Q1 FY22 are major drivers. Prescription drug sales increased in Q1 FY22 which making it difficult to attain higher growth in Q1 FY23. We reiterate BUY recommendation with TP of B...
IDLC Securities Tanay
Tanay Kumar Roy @ IDLC Securities 14 November 2022